Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Inflammation and Depression Following SCI
NCT06493071
Behavior, Behavioral Symptoms
London, Ontario, Canada
View Trial DetailsNCT Number: NCT01337908
This is a study of factors, such as pain, family support, psychological history and alcohol/substance use, that may influence whether a person experiences depression after their spinal cord injury.
Looking for future studies?
Notify Me19 year and older
All sexes
Observational
Santa Clara Valley Medical Center, San Jose, California, United States
The objective of this study is to examine the degree to which vulnerability factors are mediated by stress to increase risk for depression after SCI in a sample of adults who sustained their injuries after the age of 18 years. Participants will complete a written survey (about pain, daily activities, social support and life experiences) and a telephone interview that will provide information about these factors.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Michigan
Other
A Survey of Vulnerability Factors, Current Stress and Depression Risk in Spinal Cord Injury
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06493071
Behavior, Behavioral Symptoms
London, Ontario, Canada
View Trial DetailsNCT06583395
Adnexal Diseases, Amyotrophic Lateral Sclerosis
Palm Desert, California, United States
View Trial DetailsNCT07251491
Behavior, Behavioral Symptoms
The Bronx, New York, United States
View Trial DetailsNCT06807528
Behavior, Behavioral Symptoms
London, Ontario, Canada
View Trial Details